Literature DB >> 18400326

Optimization of Vi capsular polysaccharide production during growth of Salmonella enterica serotype Typhi Ty2 in a bioreactor.

Hyun Jang1, Yeon Kyung Yoon, Jeong Ah Kim, Hyo Seung Kim, So Jung An, Jin Ho Seo, Changfa Cui, Rodney Carbis.   

Abstract

Vi capsular polysaccharide is synthesized during growth of Salmonella typhi Ty2 and is spontaneously released from the bacterial cells into the culture medium during culture. Vi production was dependent on cell growth and the greater the cell mass the greater the production of Vi. Using fed batch culture to optimize bacterial growth resulted is an increase in cell mass and consequently Vi production. The yield of Vi obtained in fed batch culture was 415 mgl(-1), which was over three times that, obtained in batch culture. A proportion of the Vi remained cell associated in the form of a capsule and at least part of this was released from the bacterial surface by sonication. The size of the Vi polysaccharide produced was consistently high and did not change during the different phases of bacterial growth. The synthesis of Vi was also dependent upon the media components and the fermentation conditions. The presence of high concentrations of glucose at the beginning of growth inhibited the production of Vi, particularly during the stationary phase. At a concentration of 400 mM sodium phosphate the synthesis of Vi was strongly inhibited.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18400326     DOI: 10.1016/j.jbiotec.2008.02.017

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  6 in total

1.  In vitro characterization and preclinical immunogenicity of Typhax, a typhoid fever protein capsular matrix vaccine candidate.

Authors:  Thomas J Griffin; Ann Thanawastien; Robert T Cartee; John J Mekalanos; Kevin P Killeen
Journal:  Hum Vaccin Immunother       Date:  2019-05-28       Impact factor: 3.452

2.  Development of a bivalent conjugate vaccine candidate against malaria transmission and typhoid fever.

Authors:  So Jung An; Puthupparampil V Scaria; Beth Chen; Emma Barnafo; Olga Muratova; Charles Anderson; Lynn Lambert; Myung Hwa Chae; Jae Seung Yang; Patrick E Duffy
Journal:  Vaccine       Date:  2018-04-20       Impact factor: 3.641

3.  Evaluation of the immunogenicity and biological activity of the Citrobacter freundii Vi-CRM197 conjugate as a vaccine for Salmonella enterica serovar Typhi.

Authors:  Simona Rondini; Francesca Micoli; Luisa Lanzilao; Christine Hale; Allan J Saul; Laura B Martin
Journal:  Clin Vaccine Immunol       Date:  2011-01-19

4.  Strain Selection for Generation of O-Antigen-Based Glycoconjugate Vaccines against Invasive Nontyphoidal Salmonella Disease.

Authors:  Luisa Lanzilao; Giuseppe Stefanetti; Allan Saul; Calman A MacLennan; Francesca Micoli; Simona Rondini
Journal:  PLoS One       Date:  2015-10-07       Impact factor: 3.240

Review 5.  Chondroitin sulfate, hyaluronic acid and chitin/chitosan production using marine waste sources: characteristics, applications and eco-friendly processes: a review.

Authors:  José Antonio Vázquez; Isabel Rodríguez-Amado; María Ignacia Montemayor; Javier Fraguas; María Del Pilar González; Miguel Anxo Murado
Journal:  Mar Drugs       Date:  2013-03-11       Impact factor: 5.118

6.  Regulation of Vi capsular polysaccharide synthesis in Salmonella enterica serotype Typhi.

Authors:  Javier Santander; Kenneth L Roland; Roy Curtiss
Journal:  J Infect Dev Ctries       Date:  2008-12-01       Impact factor: 0.968

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.